| Financial Year |
March 31 2023 |
| Monetary Funds |
412,685,925.67 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
237,360,545.17 |
| Advances to Suppliers |
27,570,362.85 |
| Other Receivables |
19,305,884.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,574,650.87 |
| Inventories |
102,598,139.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,000,000.00 |
| Other Current Assets |
18,402,443.34 |
| Total Current Assets |
830,923,301.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
199,213,101.55 |
| Under-construction Projects |
19,844,449.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
196,905,524.72 |
| R&D expenses |
-- |
| Goodwill |
583,166,101.75 |
| Long-Term Deferred and Prepaid Expenses |
82,191,822.62 |
| Deferred Income Tax Assets |
30,858,870.31 |
| Other Non-Current Assets |
8,655,952.15 |
| Sub-Total of Non-Current Assets |
1,275,701,579.67 |
| Total Assets |
2,106,624,880.96 |
| Short-Term Loans |
15,819,390.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
160,776,436.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
58,448,745.96 |
| Taxes Payable |
32,251,412.77 |
| Interest Payable |
-- |
| Dividend Payable |
6,206,139.88 |
| Other payables |
256,980,172.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,920,552.26 |
| Other Current Liabilities |
5,403,735.76 |
| Sub-Total of Current Liabilities |
586,687,535.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,900,972.81 |
| Deferred Income Tax Liabilities |
53,890,791.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
168,527,982.18 |
| Total Liabilities |
755,215,518.01 |
| Paid-In Capital(Or Share Stock) |
642,167,010.00 |
| Capital Surplus |
2,342,772,204.68 |
| Surplus Reserve |
9,726,169.55 |
| LESS:Treasury Stock |
50,000,708.48 |
| Undistributed Profits |
-1,574,381,683.37 |
| Minority Stockholder's Interest |
34,295,590.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,317,113,772.71 |
| Owner's Equity（Stockholder's Equity） |
1,351,409,362.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,106,624,880.96 |
